Loading...

Dubai’s hospitals seek to stem haemorrhage of medical tourists

Image

19-Apr-17 Hospitals in Dubai are linking up with medical tourism facilitators as the strong dirham deters overseas patients. The number of British medical tourists fell by about 10 per cent at the American Academy of Cosmetic Surgery Hospital as the pound lost more than 16 per cent against the dirham, making cosmetic medical procedures more expensive in the UAE. [image: AACSH]

Read More

Israel's eHealth giant Natali to continue to grow presence in China

Image

06-Apr-17 Natali, Israel's largest private healthcare provider, became a subsidiary of China's Sanpower group in 2014. Since then they have implemented their eHealth/TeleHealth technologies in the Chinese market, amassing 120,000 Israeli subscribers and over 4 mn in China. When asked about the Chinese healthcare market, Nimrod Altman, CEO of Natali Healthcare Group , noted "Barriers are collapsing". [image: PRNewsFoto / Natali Healthcare Group]

Read More

India's KIMS gets USD200 mn investment from True North

Image

30-Mar-17 A USD200 mn investment from True North will fund KIMS Group's growth plans across India and the Middle East as the company strives to "become one of the largest healthcare providers in India and the Middle East in the next 3 to 5 years". KIMS is a hospital chain in Kerala with 1,500 beds across 6 hospitals.

Read More

UK's Priory Group brings behavioural healthcare to Dubai

Image

29-Mar-17 UK based Priory Group that provides top-end private healthcare, has opened its first overseas mental healthcare clinic in Dubai’s prestigious Healthcare City (DHCC). The new mental healthcare clinic will treat a wide range of conditions including depression, stress, addiction, and anxiety-related conditions including obsessive compulsive disorder (OCD) and panic attacks. [image: Emirates 24 I 7]

Read More

Israeli ophthalmic device company EyeYon Medical raises USD6.5 mn

Image

21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]

Read More
Share